BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28345481)

  • 21. A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care.
    Álvarez-Lerma F; Grau S; Echeverría-Esnal D; Martínez-Alonso M; Gracia-Arnillas MP; Horcajada JP; Masclans JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.
    Moreno S; González J; Lekander I; Martí B; Oyagüez I; Sánchez-de la Rosa R; Casado MA
    Clin Ther; 2010 Dec; 32(13):2232-45. PubMed ID: 21316539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Effectiveness of a Model Infection Control Program for Preventing Multi-Drug-Resistant Organism Infections in Critically Ill Surgical Patients.
    Jayaraman SP; Jiang Y; Resch S; Askari R; Klompas M
    Surg Infect (Larchmt); 2016 Oct; 17(5):589-95. PubMed ID: 27399263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic Evaluation of Telemedicine for Patients in ICUs.
    Yoo BK; Kim M; Sasaki T; Melnikow J; Marcin JP
    Crit Care Med; 2016 Feb; 44(2):265-74. PubMed ID: 26540398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent
    Scott RD; Slayton RB; Lessa FC; Baggs J; Culler SD; McDonald LC; Jernigan JA
    Antimicrob Resist Infect Control; 2019; 8():17. PubMed ID: 30680153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis.
    Al-Omari A; Al Mutair A; Alhumaid S; Salih S; Alanazi A; Albarsan H; Abourayan M; Al Subaie M
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):95. PubMed ID: 32600391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are labour-intensive efforts to prevent pressure ulcers cost-effective?
    Mathiesen AS; Nørgaard K; Andersen MF; Møller KM; Ehlers LH
    J Med Econ; 2013 Oct; 16(10):1238-45. PubMed ID: 23926909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost Analysis of Implementing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Plus Real-Time Antimicrobial Stewardship Intervention for Bloodstream Infections.
    Patel TS; Kaakeh R; Nagel JL; Newton DW; Stevenson JG
    J Clin Microbiol; 2017 Jan; 55(1):60-67. PubMed ID: 27795335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic impact of resistance in the community.
    Eandi M; Zara GP
    Int J Clin Pract Suppl; 1998 Jun; 95():27-38. PubMed ID: 9796553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and economic effects of an antimicrobial stewardship intervention in a surgical intensive care unit.
    Stocker H; Mehlhorn C; Jordan K; Eckholt L; Jefferys L; Arastéh K
    Infection; 2020 Aug; 48(4):509-519. PubMed ID: 32277409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infections, bacterial resistance, and antimicrobial stewardship: the emerging role of hospitalists.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S34-43. PubMed ID: 23737336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of device-associated infection rates and mortality in 3 Greek intensive care units.
    Apostolopoulou E; Raftopoulos V; Filntisis G; Kithreotis P; Stefanidis E; Galanis P; Veldekis D
    Am J Crit Care; 2013 May; 22(3):e12-20. PubMed ID: 23635940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Pneumonia in the Pediatric Critical Care Unit: An Area for Antimicrobial Stewardship.
    Dassner AM; Nicolau DP; Girotto JE
    Curr Pediatr Rev; 2017; 13(1):49-66. PubMed ID: 27917707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Cost-Effectiveness Analysis of Obtaining Blood Cultures in Children Hospitalized for Community-Acquired Pneumonia.
    Andrews AL; Simpson AN; Heine D; Teufel RJ
    J Pediatr; 2015 Dec; 167(6):1280-6. PubMed ID: 26456740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infections, bacterial resistance, and antimicrobial stewardship: the emerging role of hospitalists.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S34-43. PubMed ID: 23677633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-utility analysis of antimicrobial stewardship programme at a tertiary teaching hospital in Ethiopia.
    Gebretekle GB; Mariam DH; Mac S; Abebe W; Alemayehu T; Degu WA; Libman M; Yansouni CP; Fenta TG; Semret M; Sander B
    BMJ Open; 2021 Dec; 11(12):e047515. PubMed ID: 34921071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.